FDA.reportPublic FDA data

Retisert 0.59 MG Intravitreal Drug Implant

RxCUI
1191325
RxNorm name
Retisert 0.59 MG Intravitreal Drug Implant
Display name
Retisert 0.59 MG Intravitreal Drug Implant
Full name
Retisert 0.59 MG Intravitreal Drug Implant
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:49

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
1ab0f849-2a0d-47ce-ad05-768094da8cc9Retisert 0.59 MG Intravitreal Drug Implant [PSN] · fluocinolone acetonide 0.59 MG Drug Implant [Retisert] [SBD] · Retisert 0.59 MG Drug Implant [SY]316These highlights do not include all the information needed to use RETISERT safely and effectively. See full prescribing information for RETISERT. RETISERT (fluocinolone acetonide intravitreal implant) 0.59 mg, for intravitreal use Initial U.S. Approval: 196320260331